NYSE:SMGChemicals
Scotts Miracle-Gro Lawsuit Puts Governance And Valuation Gap In Focus
A federal judge has allowed key investor fraud claims against Scotts Miracle-Gro (NYSE:SMG) to proceed, focusing on alleged misstatements around demand, inventory, and the Hawthorne cannabis unit.
The ruling keeps senior management and the company under legal scrutiny, extending an ongoing securities lawsuit rather than dismissing it outright.
This development adds a layer of litigation and governance risk that sits alongside existing discussions of earnings, debt, and recovery efforts.
For...